optavia glp 1 Frequently Asked Questions: Lifestyle Program to Support GLP-1s OPTAVIA Lifestyle Program to Support
Description
In a study of semaglutide efficacy, the average reduction in weight from baseline was 10.2%, but 4.9% of patients achieved over 25% reduction from baseline, and 32.2% achieved less than a 5% reduction from baseline or even weight gain 5
Only the inputs change
#ASCO2026
Nausea, typically mild to moderate, affects roughly 40 percent of users during the titration phase but usually resolves within two to four weeks at each dose level
